Liverton; Nigel J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Liverton; Nigel J..The latest application filed is for "aryl and heteroaryl ether derivatives as liver x receptor beta agonists, compositions, and their use".
Company Profile
8.47.42
- Liverton; Nigel J. - Harleysville PA
- Liverton; Nigel J - Harleysville GB
- Liverton, Nigel J - Hartleysville PA
- Liverton, Nigel J. - Harteysville PA
Patent Activity
| Patent | Date |
|---|---|
| N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use Grant 10,961,215 - Rudd , et al. March 30, 2 | 2021-03-30 |
| Piperidine derivatives as liver X receptor beta agonists, compositions, and their use Grant 10,894,775 - Rudd , et al. January 19, 2 | 2021-01-19 |
| Aryl And Heteroaryl Ether Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use App 20200247754 - Kind Code | 2020-08-06 |
| N-aryl And N-heteroaryl Piperidine Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use App 20200039951 - Rudd; Michael T. ; et al. | 2020-02-06 |
| Piperidine Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use App 20190375716 - Rudd; Michael T. ; et al. | 2019-12-12 |
| Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors Grant 9,765,091 - Bolea , et al. September 19, 2 | 2017-09-19 |
| HCV NS3 protease inhibitors Grant 9,738,661 - Liverton , et al. August 22, 2 | 2017-08-22 |
| Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases Grant 9,573,939 - McComas , et al. February 21, 2 | 2017-02-21 |
| Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases Grant 9,549,917 - McComas , et al. January 24, 2 | 2017-01-24 |
| Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases Grant 9,265,773 - McComas , et al. February 23, 2 | 2016-02-23 |
| HCV NS3 Protease Inhibitors App 20150266897 - Liverton; Nigel J. ; et al. | 2015-09-24 |
| Substitued Benzofuran Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20150246902 - McComas; Casey C. ; et al. | 2015-09-03 |
| Macrocyclic compounds as antiviral agents Grant 8,927,569 - Harper , et al. January 6, 2 | 2015-01-06 |
| Hepatitis C virus NS3 protease inhibitors Grant 8,828,930 - Liverton , et al. September 9, 2 | 2014-09-09 |
| Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140213571 - Liverton; Nigel J. ; et al. | 2014-07-31 |
| Heterocyclic-substituted Benzofuran Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140199263 - McComas; Casey Cameron ; et al. | 2014-07-17 |
| Therapeutic compounds Grant 8,591,878 - McCauley , et al. November 26, 2 | 2013-11-26 |
| NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS App 20130267499 - Bolea; Christelle ; et al. | 2013-10-10 |
| Novel Fused Pyrazole Derivatives And Their Use As Allosteric Modulators Of Metabotropic Glutamate Receptors App 20130252944 - Bolea; Christelle ; et al. | 2013-09-26 |
| Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. App 20130210807 - Liverton; Nigel J ; et al. | 2013-08-15 |
| Hcv Ns3 Protease Inhibitors App 20130178413 - McCauley; John A. ; et al. | 2013-07-11 |
| HCV NS3 protease inhibitors Grant 8,461,107 - Liverton , et al. June 11, 2 | 2013-06-11 |
| HCV NS3 protease inhibitors Grant 8,377,874 - Liverton , et al. February 19, 2 | 2013-02-19 |
| HCV NS3 protease inhibitors Grant 8,377,873 - Liverton , et al. February 19, 2 | 2013-02-19 |
| Inhibitors Of Hepatitis C Virus Ns5b Polymerase App 20120328569 - McComas; Casey Cameron ; et al. | 2012-12-27 |
| HCV NS3 protease inhibitors Grant 8,309,540 - Liverton , et al. November 13, 2 | 2012-11-13 |
| HCV NS3 protease inhibitors Grant 8,278,322 - Holloway , et al. October 2, 2 | 2012-10-02 |
| HCV NS3 protease inhibitors Grant 8,216,999 - Holloway , et al. July 10, 2 | 2012-07-10 |
| Hepatitis C Virus Ns3 Protease Inhibitors App 20120121624 - Liverton; Nigel J. ; et al. | 2012-05-17 |
| HCV NS3 protease inhibitors Grant 8,138,164 - Liverton , et al. March 20, 2 | 2012-03-20 |
| Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors Grant 8,080,654 - Harper , et al. December 20, 2 | 2011-12-20 |
| Macrocyclic Quinoxaline Compounds As Hcv Ns3 Protease Inhibitors App 20110224134 - Harper; Steven ; et al. | 2011-09-15 |
| Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors Grant 7,973,040 - Harper , et al. July 5, 2 | 2011-07-05 |
| Hcv Ns3 Protease Inhibitors App 20110046161 - Liverton; Nigel J. ; et al. | 2011-02-24 |
| HCV NS3 Protease Inhibitors App 20110028494 - Holloway; M. Katharine ; et al. | 2011-02-03 |
| HCV NS3 protease inhibitors Grant 7,879,797 - Holloway , et al. February 1, 2 | 2011-02-01 |
| Therapeutic Compounds App 20110002884 - McCauley; John A. ; et al. | 2011-01-06 |
| HCV NS3 Protease Inhibitors App 20100317623 - Liverton; Nigel J. ; et al. | 2010-12-16 |
| HCV NS3 Protease Inhibitors App 20100298210 - Liverton; Nigel J. ; et al. | 2010-11-25 |
| HCV NS3 Protease Inhibitors App 20100286185 - Liverton; Nigel J ; et al. | 2010-11-11 |
| Macrocyclic Compounds As Antiviral Agents App 20100183551 - Harper; Steven ; et al. | 2010-07-22 |
| HCV NS3 Protease Inhibitors App 20100099695 - Liverton; Nigel J. ; et al. | 2010-04-22 |
| Hcv Ns3 Protease Inhibitors App 20100093779 - Liverton; Nigel J. ; et al. | 2010-04-15 |
| Macrocyclic Quinoxaline Compounds as HCV NS3 Protease Inhibitors App 20100029666 - Harper; Steven ; et al. | 2010-02-04 |
| 3-fluoro-piperidines as NMDA/NR2B antagonists Grant 7,592,360 - Liverton , et al. September 22, 2 | 2009-09-22 |
| Hcv Ns3 Protease Inhibitors App 20090124661 - HOLLOWAY; M. Katharine ; et al. | 2009-05-14 |
| HCV NS3 protease inhibitors App 20090075869 - Holloway; M. Katharine ; et al. | 2009-03-19 |
| HCV NS3 protease inhibitors Grant 7,470,664 - Holloway , et al. December 30, 2 | 2008-12-30 |
| N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists Grant 7,259,157 - Liverton , et al. August 21, 2 | 2007-08-21 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Grant 7,217,716 - Claiborne , et al. May 15, 2 | 2007-05-15 |
| (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds Grant 7,196,095 - Biftu , et al. March 27, 2 | 2007-03-27 |
| HCV NS3 protease inhibitors App 20070027071 - Holloway; M. Katharine ; et al. | 2007-02-01 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Grant 7,053,089 - Claiborne , et al. May 30, 2 | 2006-05-30 |
| Isoquinolinone potassium channels inhibitors Grant 6,870,055 - Claremon , et al. March 22, 2 | 2005-03-22 |
| Radioligand and binding assay Grant 6,838,291 - Butcher , et al. January 4, 2 | 2005-01-04 |
| N-substituted nonaryl-heterocyclic nmda/nr2b antagonists App 20040209889 - Claiborne, Christopher F ; et al. | 2004-10-21 |
| (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds App 20040176396 - Biftu, Tesfaye ; et al. | 2004-09-09 |
| Substituted imidazoles having cytokine inhibitory activity Grant 6,767,908 - Claiborne , et al. July 27, 2 | 2004-07-27 |
| Isoquinolinone potassium channels inhibitors App 20040044030 - Claremon, David A ; et al. | 2004-03-04 |
| Substituted pyridazines having cytokine inhibitory activity Grant 6,602,872 - McIntyre , et al. August 5, 2 | 2003-08-05 |
| N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists App 20030119811 - Liverton, Nigel J. ; et al. | 2003-06-26 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists App 20020165241 - Claiborne, Christopher F. ; et al. | 2002-11-07 |
| Radioligand and binding assay App 20020034730 - Butcher, John W. ; et al. | 2002-03-21 |
| Substituted imidazoles having cytokine inhibitory activity App 20020026056 - Claiborne, Christopher F. ; et al. | 2002-02-28 |
| Iminopyrimidine NMDA NR2B receptor antagonists App 20020013329 - Claremon, David A. ; et al. | 2002-01-31 |
| 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists Grant 6,316,474 - McCauley , et al. November 13, 2 | 2001-11-13 |
| Substituted imidazoles having cytokine inhibitory activity Grant 6,207,687 - Claiborne , et al. March 27, 2 | 2001-03-27 |
| Substituted imidazoles having cytokine inhibitory activity Grant 5,859,041 - Liverton , et al. January 12, 1 | 1999-01-12 |
| 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use Grant 5,837,719 - de Laszlo , et al. November 17, 1 | 1998-11-17 |
| 2-substituted aryl pyrroles, compositions containing such compounds and methods of use Grant 5,792,778 - de Laszlo , et al. August 11, 1 | 1998-08-11 |
| Substituted imidazoles having anti-cancer and cytokine inhibitory activity Grant 5,717,100 - Selnick , et al. February 10, 1 | 1998-02-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 